Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Reuters says the company reported positive preclinical data for urinary tract and pulmonary infection indications using Bisphosphocin compounds, with Bisphosphocin Nu-3 Phase 2a topline data expected in Q1 2027.
Lakewood-Amedex Biotherapeutics (LABT) announced positive preclinical data in urinary tract and pulmonary infection indications using Bisphosphocin® compounds.